|
|
Expression significance of multiple serum tumor markers in COPD acute exacerbation |
FU Dongqin XU Zhijian JIANG Yong |
Department of Laboratory, Fuzhou First People′s Hospital |
|
|
Abstract Objective To investigate the expression significance of multiple serum tumor markers in acute exacerbation of chronic obstructive pulmonary disease (COPD). Methods A total of 80 COPD patients admitted to Fuzhou First People′s Hospital from July 2019 to December 2020 were selected as the research objects, and were divided into acute exacerbation group and stable stage group according to stages, with 40 cases in each group, and 40 healthy subjects in the same period were selected as the control group. Carcinoembryonic antigen (CEA), glycochain antigen 19-9 (CA19-9), carbohydrate antigen 125 (CA125) and neuron specific enolase (NSE) were detected and compared among the three groups. The correlation between NSE level and CEA, CA19-19 and CA125 levels were analyzed, and the diagnostic value of various serum tumor markers in the acute exacerbation of COPD by single and combined detection were analyzed. Results CEA, CA19-9, CA125 and NSE levels in COPD acute exacerbation group were higher than those in control group and stable group, with statistical significance (P<0.05). CA19-9 and CA125 in stable group were higher than those in control group, the difference was statistically significant (P<0.05). NSE levels were negatively correlated with CEA, CA19-19 and CA125 levels, while CA125 levels were positively correlated with CEA and CA19-9 levels.The level of CA19-9 was positively correlated with CEA level (P<0.05). In single test, the sensitivity of CA125 was higher, reaching 65.0%; CEA had a high specificity, reaching 85.0%. The sensitivity and specificity of CEA, CA19-9,CA125, and NSE were determined, reached 92.5%, 91.3%, respectively. Conclusion COPD acute weighting period was raised in serum tumor markers CEA, CA19-19, CA125, and NSE levels, and detected that it can help to judge patients with COPD in clinical practice to provide a basis for developing scientific treatment programs.
|
|
|
|
|
[1] |
林展增.中国慢性阻塞性肺疾病流行病学研究进展[J].河北北方学院学报(自然科学版),2020,36(8):49-51,56.
|
[2] |
邵信涛.血清肿瘤标志物在慢性阻塞性肺疾病中的水平及临床意义[J].慢性病学杂志,2019,20(11):1663-1664.
|
[3] |
魏文静,任钰荣,发如克·帕尔哈提,等.间质性肺疾病与肿瘤标志物相关性的研究进展[J].新疆中医药,2018,36(6):86-89.
|
[4] |
王鹏,江晓华,冉凤伟,等.多种血清肿瘤标志物在转移性乳腺癌中的诊断价值及临床意义[J].国际检验医学杂志,2020,41(21):2595-2598,2603.
|
[5] |
王玲,申鸿.癌胚抗原、糖类抗原、CA(125)、血管生成素、细胞角蛋白19 片段及甲胎蛋白检测在肺癌诊断中的临床研究[J].陕西医学杂志,2019,48(8):1080-1084.
|
[6] |
李静,李鑫,张辉,等.癌胚抗原、糖类抗原125、糖类抗原199 对Ⅲ期结肠癌根治术后患者预后的价值[J].中国临床医生杂志,2021,49(8):948-951.
|
[7] |
李天林,余薇,陈亮,等.肺部穿刺活检联合血清SCC、CEA、NSE 诊断肺癌的价值[J].福建医药杂志,2021,43(3):26-29.
|
[8] |
詹思延.流行病学[M].7 版.北京:人民卫生出版社,2012.
|
[9] |
王传新.肿瘤标志物的临床应用与研究进展[J].中华检验医学杂志,2014(9):641-644.
|
[10] |
李秀业,刘领,薛兵.N-端脑钠肽前体与肿瘤坏死因子-α 对慢性阻塞性肺疾病急性加重期及合并全身炎症反应综合征诊断的意义[J].中国医药科学,2021,11(3):224-227.
|
[11] |
林蕊艳,张新,李晓辉,等.间质性肺疾病血清肿瘤标记物升高的临床意义[J].中国临床药理学杂志,2011,27(8):623-625.
|
[12] |
袁帅.血清癌胚抗原水平与肺纤维化严重程度相关性研究[D].南宁:广西医科大学,2019.
|
[13] |
孔延龙,李云龙,项红军,等.结直肠癌患者血清糖类抗原19-9 胰岛素样生长因子-1 趋化因子-21 表达及临床意义[J].山西医药杂志,2020,49(17):2255-2257.
|
[14] |
吕剑.血清CEA、CA125、CA19-9 联合检测在肺癌患者治疗中的临床价值[J].国际检验医学杂志,2018,39(11):1322-1325,1328.
|
[15] |
曹淑芳,蔡少华,刘长庭.CA19-9 显著升高的特发性肺纤维化一例——附文献复习[J].临床内科杂志,2003(6):300-302.
|
[16] |
季巧英,赵书山,舒彩敏.肿瘤标志物在特发性肺纤维化患者的表达及意义[J].医学研究杂志,2009,38(10):39-41.
|
[17] |
辛玉琦,巨宇叶,王晓慧.卵巢癌生物标志物及早期诊断的研究进展[J].国际妇产科学杂志,2020,47(5):544-549.
|
[18] |
罗伟彬,吴国栋,姚达.CEA、NSE、CA125 及CA199 在孤立性肺结节诊断中的价值[J].海南医学院学报,2013,(1):107-109.
|
[19] |
干丽萍,李时悦,林心情,等.肿瘤标记物与特发性肺间质纤维化严重程度的相关分析[J].实用医学杂志,2013,29(20):3333-3335.
|
|
|
|